Flanigan R C
Department of Urology, Loyola University Medical Center, Maywood, IL 60153, USA.
Semin Urol Oncol. 1996 Nov;14(4):227-9.
The role of surgery in metastatic renal cancer continues to evolve. Although of documented benefit in patients with significant symptoms from their primary tumor and in patients with solitary (or resectable) metastatic disease, the clinical usefulness of nephrectomy in patients with unresectable metastases remains to be proved. Important clinical trials are under way to answer this question.
手术在转移性肾癌中的作用仍在不断演变。虽然已证明手术对有原发肿瘤显著症状的患者以及有孤立性(或可切除)转移病灶的患者有益,但肾切除术在无法切除转移灶的患者中的临床实用性仍有待证实。重要的临床试验正在进行,以回答这个问题。